Table 2.
Total population (n) | Number of cases (%) | Prevalence per 100 000 | 95% CI | |
Boys and men | ||||
0–14 years | 151 839 | 19 (16.0) | 12.5 | (7.8 to 20.0) |
15–34 years | 200 958 | 32 (26.9) | 15.9 | (11.1 to 22.8) |
35–49 years | 143 652 | 19 (16.0) | 13.2 | (8.2 to 21.1) |
50–64 years | 116 796 | 29 (24.4) | 24.8 | (16.9 to 36.2) |
≥65 years | 74 244 | 20 (16.8) | 26.9 | (16.9 to 42.4) |
Total | 687 492 | 119 (100.0) | 17.3 | (14.4 to 20.8) |
Standardised | – | – | 16.6 | (10.9 to 25.2) |
Girls and women | ||||
0–14 years | 144 516 | 8 (6.8) | 5.5 | (2.6 to 11.4) |
15–34 years | 208 659 | 27 (23.1) | 12.9 | (8.7 to 19.1) |
35–49 years | 160 485 | 29 (24.8) | 18.1 | (12.3 to 26.3) |
50–64 years | 125 284 | 32 (27.4) | 25.5 | (17.8 to 36.5) |
≥65 years | 88 905 | 21 (18.0) | 23.6 | (15.0 to 36.8) |
Total | 728 058 | 117 (100.0) | 16.1 | (13.4 to 19.3) |
Standardised | – | – | 14.6 | (9.6 to 22.4) |
Total sample | ||||
0–14 years | 296 358 | 27 (11.4) | 9.1 | (6.1 to 13.5) |
15–34 years | 409 620 | 59 (25.0) | 14.4 | (11.1 to 18.1) |
35–49 years | 304 134 | 48 (20.3) | 15.8 | (11.8 to 21.1) |
50–64 years | 242 280 | 61 (25.9) | 25.2 | (19.4 to 32.6) |
≥65 years | 163 152 | 41 (17.4) | 25.1 | (18.3 to 34.4) |
Total | 1 415 550 | 236 (100.0) | 16.7 | (14.6 to 19.0) |
Standardised* | – | – | 15.6 | (11.6 to 21.0) |
*Standardised to the WHO standard population.